FRCPath Part 1 Practice Questions - FRCPath Part 1 Examination Exam

Access More Questions

A breast core biopsy shows invasive carcinoma. Which combination of biomarkers determines whether the patient is offered anti-HER2 therapy and endocrine therapy?

CK5/6 and EGFR ER, PR and HER2 Ki-67 and p53 E-cadherin and CK7

Correct Answer:

ER, PR and HER2

Access more questions from this quiz

Continue to FRCPath Part 1 Practice Questions - FRCPath Part 1 Examination Exam for more practice questions and the full quiz experience.

Access More Questions